PLS Shares Rebound Stretches To 20%, As Lithium Moves Off Lows

PLS Group shares (ASX: PLS) continued to rebound on Wednesday, adding 4.27% to close at A$4.88, up 20.79% over the past two weeks. The move brings the PLS share price back to an old resistance level, one that has yet to be seriously tested after the 40% drawdown from June 1st into early August.

Lithium optimism is doing the heavy lifting, with supply tightening after a period of pressure. The recent June quarter results, published late last month, showed a meaningful step-up in realised lithium selling prices and a corresponding lift in revenue, giving the market a concrete earnings hook to reprice the stock higher. That kind of operating leverage is exactly what investors in a high-beta commodity name like PLS are positioned to capture, and it appears the market is still digesting those numbers and adjusting exposure accordingly.

The company’s place as a leveraged play on lithium demand has been continually reinforced, with the stock’s balance-sheet position and its operating leverage heavily tied to spodumene prices. So when lithium pricing moves, PLS’ earnings can move by a larger proportion, making it a natural vehicle for traders who want concentrated exposure to the commodity cycle. That being so, it is worth noting that cost pressures have not disappeared.

The June quarter update also flagged higher production costs, including diesel and restart expenses, which can act as a drag on margins if lithium prices soften or plateau. That tension between revenue upside and cost creep is likely to remain a feature of how the market values Pilbara through the rest of the year.

The average price target in the analyst community sits at A$5.15, suggesting a ~5% upside from here, pointing to a cautiously constructive view. From a technical standpoint, the current price is above its upper Bollinger Band,  signalling an extended move and expanding near-term volatility, as we have seen in price over the past two weeks. Volatility is rising, and the stock’s beta of 2.55 against the broader Australian market underscores just how sensitive the stock is to shifts in risk appetite. When the sector moves, this stock tends to move by more, in both directions.

The key question from here is whether lithium pricing can sustain or extend recent gains. If spodumene prices continue to firm and the next quarterly update reflects that in realised revenue, the recent move could prove to be the beginning of a broader rebound, yet this resistance zone will need to be cleared first. We would be watching for a clear break above A$5, with volume more than 1.5x the ADV.